Send to a Friend Font Size: Increase Decrease

IPHA and SOBI Related Headlines

Aug 10, 2026 02:33AM Sobi licenses lacutamab from Innate Pharma in $75M upfront deal
Aug 10, 2026 02:32AM Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma

IPHA and SOBI Related Press Releases

Aug 10, 2026 02:32AM Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma

IPHA and SOBI Related SEC Filings